Anti-angiogenic properties of rapamycin on human retinal pericytes in an in vitro model of neovascular AMD via inhibition of the mTOR pathway

Erstveröffentlichung
2022Authors
Asani, Ben
Siedlecki, Jakob
Wertheimer, Christian
Liegl, Raffael
Wolf, Armin
Wissenschaftlicher Artikel
Published in
BMC Ophthalmology ; 22 (2022). - Art.-Nr. 138. - eISSN 1471-2415
Link to publication
https://dx.doi.org/10.1186/s12886-022-02334-wInstitutions
UKU. Klinik für AugenheilkundeSubject headings
[Free subject headings]: Age related macular degeneration | Choroidal neovascularization | VEGF | PDGF | Rapamycin | Sirolimus | mTOR | GROWTH-FACTOR | TUBE FORMATION | CELL-GROWTH | PROTEIN | DRUG | ACTIVATION[DDC subject group]: DDC 610 / Medicine & health